Ophthalmology · Scranton, PA
NPI
1053362574
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
200 Mifflin Ave
Scranton, PA, 18503
Phone (570) 342-3145
Groups this clinician bills Medicare through
Medicare paid, 2024
$391K
3,460 services
Medicare patients, 2024
1,213
Average age 76
Drug cost, 2024
$390K
2,834 prescriptions
Company payments, 2025
$409
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher S Jordan was code 92136 (ultrasound - nonspecific), 553 times for 347 patients. In total Christopher S Jordan billed 3,460 services in 40 codes, and Medicare paid $391K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92136 Ultrasound - Nonspecific | Office | 553 | 347 | $26.75 | $15K |
| 99214 Office E&M - Established | Office | 540 | 317 | $79.69 | $43K |
| 92014 Ophthalmological E&M | Office | 508 | 489 | $77.95 | $40K |
| 66984 Cataract Surgery | Facility | 446 | 271 | $355.39 | $159K |
| 99213 Office E&M - Established | Office | 348 | 219 | $56.91 | $20K |
| 92133 Computerized Ophthalmic Imaging | Office | 142 | 137 | $22.87 | $3,247 |
| 92083 Vision, Hearing, and Speech Services | Office | 119 | 111 | $41.14 | $4,895 |
| 66821 Cataract Surgery | Facility | 118 | 94 | $230.54 | $27K |
| 99204 Office E&M - New | Office | 116 | 116 | $88.82 | $10K |
| 99212 Office E&M - Established | Office | 114 | 101 | $38.01 | $4,333 |
| 68841 Eye | Facility | 81 | 60 | $11.85 | $960 |
| 92004 Ophthalmological E&M | Office | 80 | 80 | $75.31 | $6,025 |
| 92134 Computerized Ophthalmic Imaging | Office | 76 | 70 | $25.91 | $1,969 |
| 66982 Cataract Surgery | Facility | 61 | 43 | $479.87 | $29K |
| 92012 Ophthalmological E&M | Office | 33 | 32 | $57.99 | $1,914 |
By year: 2022 $368K for 3,349 services; 2023 $399K for 3,223 services; 2024 $391K for 3,460 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher S Jordan prescribed most often to Medicare patients was Latanoprost, with 678 prescriptions and refills. In total Christopher S Jordan wrote 2,834 Medicare prescriptions that cost $390K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 678 | 944 | 124 | $6,585 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 401 | 782 | 102 | $8,827 |
| Lumigan Bimatoprost | 170 | 283 | 40 | $78K |
| Prednisolone Acetate Generic | 166 | 263 | 79 | $7,252 |
| Brimonidine Tartrate Generic | 132 | 181 | 27 | $10K |
| Fluorometholone Generic | 130 | 215 | 55 | $9,069 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 128 | 149 | 76 | $5,482 |
| Timolol Maleate Generic | 91 | 173 | 23 | $1,075 |
| Restasis Cyclosporine | 77 | 131 | 30 | $77K |
| Cyclosporine Generic | 77 | 124 | 27 | $27K |
| Doxycycline Hyclate Generic | 77 | 86 | 17 | $1,326 |
| Rhopressa Netarsudil Mesylate | 64 | 68 | 12 | $20K |
| Dorzolamide Hcl Generic | 56 | 97 | 18 | $1,035 |
| Valacyclovir Valacyclovir Hcl | 47 | 71 | 12 | $1,552 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 46 | 54 | Under 11 | $16K |
Brand drugs: - claims; generic drugs: 1,859 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher S Jordan $409 ($409 in general payments such as food, travel and fees) from 8 companies. The largest payer was Alcon Vision LLC with $237.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 7 | $237 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $45.15 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $32.98 |
| RxSight Inc RXST | 1 | $24.97 |
| Sight Sciences, Inc. SGHT | 1 | $19.97 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $18.79 |
| Rayner Intraocular Lenses Limited | 1 | $15.81 |
| Biotissue Holdings Inc. | 1 | $14.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.